{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:26:14Z","timestamp":1780734374055,"version":"3.54.1"},"reference-count":120,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T00:00:00Z","timestamp":1606694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","award":["RG1181642744DF59"],"award-info":[{"award-number":["RG1181642744DF59"]}],"id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","award":["RM11715C773949E3"],"award-info":[{"award-number":["RM11715C773949E3"]}],"id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","award":["RG116154C9214D1A"],"award-info":[{"award-number":["RG116154C9214D1A"]}],"id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004588","name":"Istituto Pasteur-Fondazione Cenci Bolognetti","doi-asserted-by":"publisher","award":["Under 45 U-4.IT"],"award-info":[{"award-number":["Under 45 U-4.IT"]}],"id":[{"id":"10.13039\/501100004588","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2018-12366381"],"award-info":[{"award-number":["GR-2018-12366381"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s13311-020-00978-4","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T16:02:45Z","timestamp":1606752165000},"page":"340-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["The Dysregulation of OGT\/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome"],"prefix":"10.1016","volume":"18","author":[{"given":"Ilaria","family":"Zuliani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Lanzillotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Tramutola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Francioso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pagnotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Perluigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2013-209X","authenticated-orcid":false,"given":"Fabio","family":"Di Domenico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-020-00978-4_bib1","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1474-4422(16)00063-6","article-title":"Dementia in Down's syndrome","volume":"15","author":"Ballard","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-020-00978-4_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/mrdd.20157","article-title":"Epidemiology of Down syndrome","volume":"13","author":"Sherman","year":"2007","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"10.1007\/s13311-020-00978-4_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/eurpub\/ckl103","article-title":"The four ages of Down syndrome","volume":"17","author":"Bittles","year":"2007","journal-title":"Eur J Pub Health"},{"key":"10.1007\/s13311-020-00978-4_bib4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/gim.2016.127","article-title":"Estimation of the number of people with Down syndrome in the United States","volume":"19","author":"de Graaf","year":"2017","journal-title":"Genet Med"},{"key":"10.1007\/s13311-020-00978-4_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.nicl.2017.10.022","article-title":"Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome","volume":"17","author":"Neale","year":"2018","journal-title":"Neuroimage Clin"},{"key":"10.1007\/s13311-020-00978-4_bib6","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrn3983","article-title":"A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome","volume":"16","author":"Wiseman","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"10.1007\/s13311-020-00978-4_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1007\/s13311-020-00978-4_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41582-018-0132-6","article-title":"Dementia in Down syndrome: unique insights for Alzheimer disease research","volume":"15","author":"Lott","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1007\/s13311-020-00978-4_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1567205012666151020114607","article-title":"Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology","volume":"13","author":"Head","year":"2016","journal-title":"Curr Alzheimer Res"},{"key":"10.1007\/s13311-020-00978-4_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11065-017-9341-9","article-title":"The Early Presentation of Dementia in People with Down Syndrome: a Systematic Review of Longitudinal Studies","volume":"27","author":"Lautarescu","year":"2017","journal-title":"Neuropsychol Rev"},{"key":"10.1007\/s13311-020-00978-4_bib11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40478-018-0559-4","article-title":"The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer's disease in individuals with Down syndrome","volume":"6","author":"Davidson","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"10.1007\/s13311-020-00978-4_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ddrr.1123","article-title":"People with intellectual disability: what do we know about adulthood and life expectancy?","volume":"18","author":"Coppus","year":"2013","journal-title":"Dev Disabil Res Rev"},{"key":"10.1007\/s13311-020-00978-4_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/nbdi.1996.0003","article-title":"Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation","volume":"3","author":"Lemere","year":"1996","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-020-00978-4_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.freeradbiomed.2017.08.009","article-title":"mTOR in Down syndrome: Role in Ass and tau neuropathology and transition to Alzheimer disease-like dementia","volume":"114","author":"Di Domenico","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"10.1007\/s13311-020-00978-4_bib15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fnins.2020.00670","article-title":"Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions","volume":"14","author":"Dierssen","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1007\/s13311-020-00978-4_bib16","doi-asserted-by":"crossref","first-page":"104772","DOI":"10.1016\/j.nbd.2020.104772","article-title":"Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome","volume":"137","author":"Tramutola","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-020-00978-4_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2217\/ahe.11.89","article-title":"Early intranasal insulin therapy halts progression of neurodegeneration: progress in Alzheimer's disease therapeutics","volume":"8","author":"de la Monte","year":"2012","journal-title":"Aging Health"},{"key":"10.1007\/s13311-020-00978-4_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.nbd.2014.05.001","article-title":"Early detection of Alzheimer's disease using PiB and FDG PET","volume":"72","author":"Cohen","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-020-00978-4_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cpet.2017.03.001","article-title":"PET Imaging for Early Detection of Alzheimer's Disease: From Pathologic to Physiologic Biomarkers","volume":"12","author":"Bao","year":"2017","journal-title":"PET Clin"},{"key":"10.1007\/s13311-020-00978-4_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000289222","article-title":"Early detection of Alzheimer's disease with PET imaging","volume":"7","author":"Berti","year":"2010","journal-title":"Neurodegener Dis"},{"key":"10.1007\/s13311-020-00978-4_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3233\/JAD-2011-101392","article-title":"Dementia, diabetes, Alzheimer's disease, and insulin resistance in the brain: progress, dilemmas, new opportunities, and a hypothesis to tackle intersecting epidemics","volume":"25","author":"Kuljis","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s13311-020-00978-4_bib22","first-page":"1144","article-title":"Neuropathological role of PI3K\/Akt\/mTOR axis in Down syndrome brain","volume":"2014","author":"Perluigi","year":"1842","journal-title":"Biochim Biophys Acta"},{"key":"10.1007\/s13311-020-00978-4_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.febslet.2007.12.035","article-title":"Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease","volume":"582","author":"Liu","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1007\/s13311-020-00978-4_bib24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ana.20474","article-title":"Mitochondrial abnormalities in Alzheimer brain: mechanistic implications","volume":"57","author":"Bubber","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-020-00978-4_bib25","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1073\/pnas.0400348101","article-title":"O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease","volume":"101","author":"Liu","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-020-00978-4_bib26","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/brain\/awp099","article-title":"Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease","volume":"132","author":"Liu","year":"2009","journal-title":"Brain."},{"key":"10.1007\/s13311-020-00978-4_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jnc.14242","article-title":"Nutrient-driven O-GlcNAc in proteostasis and neurodegeneration","volume":"144","author":"Akan","year":"2018","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-020-00978-4_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.arr.2018.05.003","article-title":"O-GlcNAcylation and neuronal energy status: Implications for Alzheimer's disease","volume":"46","author":"Pinho","year":"2018","journal-title":"Ageing Res Rev"},{"key":"10.1007\/s13311-020-00978-4_bib29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0006-8993(02)04158-6","article-title":"Localization of the O-GlcNAc transferase and O-GlcNAc-modified proteins in rat cerebellar cortex","volume":"966","author":"Akimoto","year":"2003","journal-title":"Brain Res"},{"key":"10.1007\/s13311-020-00978-4_bib30","doi-asserted-by":"crossref","first-page":"9838","DOI":"10.1074\/jbc.M010420200","article-title":"Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain","volume":"276","author":"Gao","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-020-00978-4_bib31","doi-asserted-by":"crossref","first-page":"9308","DOI":"10.1074\/jbc.272.14.9308","article-title":"Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats","volume":"272","author":"Kreppel","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-020-00978-4_bib32","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1046\/j.1471-4159.2003.01939.x","article-title":"UDP-N-acetylglucosaminyl transferase (OGT) in brain tissue: temperature sensitivity and subcellular distribution of cytosolic and nuclear enzyme","volume":"86","author":"Okuyama","year":"2003","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-020-00978-4_bib33","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1074\/jbc.AW119.003226","article-title":"Nutrient regulation of signaling and transcription","volume":"294","author":"Hart","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-020-00978-4_bib34","unstructured":"Hart GW, Akimoto Y. The O-GlcNAc Modification. In: nd, Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, et al., editors. Essentials of Glycobiology. Cold Spring Harbor (NY)2009."},{"key":"10.1007\/s13311-020-00978-4_bib35","doi-asserted-by":"crossref","first-page":"13793","DOI":"10.1073\/pnas.0806216105","article-title":"Cross-talk between GlcNAcylation and phosphorylation: site-specific phosphorylation dynamics in response to globally elevated O-GlcNAc","volume":"105","author":"Wang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-020-00978-4_bib36","doi-asserted-by":"crossref","unstructured":"Hastings NB, Wang XH, Song LX, Butts BD, Grotz D, Hargreaves R, et al. Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice. Mol Neurodegener 2017;12.","DOI":"10.1186\/s13024-017-0181-0"},{"key":"10.1007\/s13311-020-00978-4_bib37","first-page":"167","article-title":"Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins--a role in nuclear localization","volume":"2003","author":"Lefebvre","year":"1619","journal-title":"Biochim Biophys Acta"},{"key":"10.1007\/s13311-020-00978-4_bib38","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.phrs.2016.01.006","article-title":"Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease","volume":"105","author":"Gatta","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1007\/s13311-020-00978-4_bib39","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.bbrc.2017.06.067","article-title":"O-GlcNAcylation of amyloid-beta precursor protein at threonine 576 residue regulates trafficking and processing","volume":"490","author":"Chun","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1007\/s13311-020-00978-4_bib40","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1073\/pnas.1808845116","article-title":"alpha-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson's disease","volume":"116","author":"Levine","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-020-00978-4_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-2006-9101","article-title":"Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-GlcNAcylation","volume":"9","author":"Gong","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s13311-020-00978-4_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14737175.2019.1540932","article-title":"Therapeutic potential of rescuing protein O-GlcNAcylation in tau-related pathologies","volume":"19","author":"Di Domenico","year":"2019","journal-title":"Expert Rev Neurother"},{"key":"10.1007\/s13311-020-00978-4_bib43","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jnr.490410214","article-title":"Beta-amyloid precursor protein is modified with O-linked N-acetylglucosamine","volume":"41","author":"Griffith","year":"1995","journal-title":"J Neurosci Res"},{"key":"10.1007\/s13311-020-00978-4_bib44","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jalz.2016.02.011","article-title":"O-GlcNAcylation: A regulator of tau pathology and neurodegeneration","volume":"12","author":"Gong","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s13311-020-00978-4_bib45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/01616412.2015.1133485","article-title":"Roles of O-GlcNAcylation on amyloid-beta precursor protein processing, tau phosphorylation, and hippocampal synapses dysfunction in Alzheimer's disease","volume":"38","author":"Zheng","year":"2016","journal-title":"Neurol Res"},{"key":"10.1007\/s13311-020-00978-4_bib46","first-page":"1333","article-title":"Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain","volume":"2014","author":"Forster","year":"1842","journal-title":"Biochim Biophys Acta"},{"key":"10.1007\/s13311-020-00978-4_bib47","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1006\/bbrc.1995.2149","article-title":"O-linked N-acetylglucosamine is upregulated in Alzheimer brains","volume":"213","author":"Griffith","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1007\/s13311-020-00978-4_bib48","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1089\/ars.2016.6759","article-title":"The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics","volume":"26","author":"Di Domenico","year":"2017","journal-title":"Antioxid Redox Signal"},{"key":"10.1007\/s13311-020-00978-4_bib49","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00335-011-9357-z","article-title":"Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn","volume":"22","author":"Reinholdt","year":"2011","journal-title":"Mamm Genome"},{"key":"10.1007\/s13311-020-00978-4_bib50","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nchembio.96","article-title":"A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo","volume":"4","author":"Yuzwa","year":"2008","journal-title":"Nat Chem Biol"},{"key":"10.1007\/s13311-020-00978-4_bib51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.mex.2014.10.007","article-title":"Iba1 immunoreactivity is enhanced following an antigen retrieval treatment with EDTA, pH 6.0","volume":"1","author":"Ghatak","year":"2014","journal-title":"MethodsX"},{"key":"10.1007\/s13311-020-00978-4_bib52","doi-asserted-by":"crossref","unstructured":"Zachara NE, Vosseller K, Hart GW. Detection and analysis of proteins modified by O-linked N-acetylglucosamine. Curr Protoc Mol Biol. 2011;Chapter 17:Unit 17 6.","DOI":"10.1002\/0471142727.mb1706s95"},{"key":"10.1007\/s13311-020-00978-4_bib53","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1172\/JCI118876","article-title":"Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance","volume":"98","author":"Hebert","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1007\/s13311-020-00978-4_bib54","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods."},{"key":"10.1007\/s13311-020-00978-4_bib55","first-page":"3309","article-title":"Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease","volume":"2018","author":"Tramutola","year":"1864","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"10.1007\/s13311-020-00978-4_bib56","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3233\/JAD-170211","article-title":"Early and Persistent O-GlcNAc Protein Modification in the Streptozotocin Model of Alzheimer's Disease","volume":"61","author":"Dos Santos","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s13311-020-00978-4_bib57","doi-asserted-by":"crossref","first-page":"15120","DOI":"10.1073\/pnas.1606899113","article-title":"Loss of O-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegeneration","volume":"113","author":"Wang","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-020-00978-4_bib58","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3389\/fendo.2018.00595","article-title":"Direct Crosstalk Between O-GlcNAcylation and Phosphorylation of Tau Protein Investigated by NMR Spectroscopy","volume":"9","author":"Bourre","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1007\/s13311-020-00978-4_bib59","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.sbi.2003.08.003","article-title":"Dynamic interplay between O-GlcNAc and O-phosphate: the sweet side of protein regulation","volume":"13","author":"Slawson","year":"2003","journal-title":"Curr Opin Struct Biol"},{"key":"10.1007\/s13311-020-00978-4_bib60","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3233\/JAD-160841","article-title":"Glucose Transporters in Brain: In Health and in Alzheimer's Disease","volume":"55","author":"Szablewski","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s13311-020-00978-4_bib61","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cmet.2012.12.017","article-title":"Glucose sensor O-GlcNAcylation coordinates with phosphorylation to regulate circadian clock","volume":"17","author":"Kaasik","year":"2013","journal-title":"Cell Metab"},{"key":"10.1007\/s13311-020-00978-4_bib62","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fendo.2014.00221","article-title":"O-GlcNAc: A Bittersweet Switch in Liver","volume":"5","author":"Zhang","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1007\/s13311-020-00978-4_bib63","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.diabet.2010.09.001","article-title":"O-GlcNAc modification, insulin signaling and diabetic complications","volume":"36","author":"Issad","year":"2010","journal-title":"Diabetes Metab"},{"key":"10.1007\/s13311-020-00978-4_bib64","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.1074\/jbc.M109.077818","article-title":"Regulation of insulin receptor substrate 1 (IRS-1)\/AKT kinase-mediated insulin signaling by O-Linked beta-N-acetylglucosamine in 3T3-L1 adipocytes","volume":"285","author":"Whelan","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-020-00978-4_bib65","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/10409238.2015.1135102","article-title":"New insights: A role for O-GlcNAcylation in diabetic complications","volume":"51","author":"Peterson","year":"2016","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1007\/s13311-020-00978-4_bib66","doi-asserted-by":"crossref","first-page":"34614","DOI":"10.1038\/srep34614","article-title":"Identification of the nuclear localisation signal of O-GlcNAc transferase and its nuclear import regulation","volume":"6","author":"Seo","year":"2016","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-020-00978-4_bib67","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1074\/jbc.M807431200","article-title":"In vivo modulation of O-GlcNAc levels regulates hippocampal synaptic plasticity through interplay with phosphorylation","volume":"284","author":"Tallent","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-020-00978-4_bib68","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1074\/jbc.M113.512814","article-title":"O-linked beta-N-acetylglucosamine (O-GlcNAc) site thr-87 regulates synapsin I localization to synapses and size of the reserve pool of synaptic vesicles","volume":"289","author":"Skorobogatko","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-020-00978-4_bib69","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2818.2006.01706.x","article-title":"A guided tour into subcellular colocalization analysis in light microscopy","volume":"224","author":"Bolte","year":"2006","journal-title":"J Microsc"},{"key":"10.1007\/s13311-020-00978-4_bib70","doi-asserted-by":"crossref","first-page":"463909","DOI":"10.1155\/2012\/463909","article-title":"Age-related neurodegeneration and memory loss in down syndrome","volume":"2012","author":"Lockrow","year":"2012","journal-title":"Curr Gerontol Geriatr Res"},{"key":"10.1007\/s13311-020-00978-4_bib71","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cbpa.2019.09.001","article-title":"Molecular mechanisms regulating O-linked N-acetylglucosamine (O-GlcNAc)-processing enzymes","volume":"53","author":"King","year":"2019","journal-title":"Curr Opin Chem Biol"},{"key":"10.1007\/s13311-020-00978-4_bib72","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.jmb.2014.01.004","article-title":"O-GlcNAc modification of tau directly inhibits its aggregation without perturbing the conformational properties of tau monomers","volume":"426","author":"Yuzwa","year":"2014","journal-title":"J Mol Biol"},{"key":"10.1007\/s13311-020-00978-4_bib73","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bbrc.2010.12.080","article-title":"O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-beta precursor protein (APP)","volume":"404","author":"Jacobsen","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1007\/s13311-020-00978-4_bib74","doi-asserted-by":"crossref","unstructured":"Lanzillotta C, Zuliani I, Tramutola A, Barone E, Blarzino C, Folgiero V, et al. Chronic PERK induction promotes Alzheimer-like neuropathology in Down syndrome: Insights for therapeutic intervention. Prog Neurobiol 2020:101892.","DOI":"10.1016\/j.pneurobio.2020.101892"},{"key":"10.1007\/s13311-020-00978-4_bib75","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/dneu.22716","article-title":"Plasma metabolites related to cellular energy metabolism are altered in adults with Down syndrome and Alzheimer's disease","volume":"79","author":"Gross","year":"2019","journal-title":"Dev Neurobiol"},{"key":"10.1007\/s13311-020-00978-4_bib76","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1038\/s41598-018-20834-y","article-title":"Plasma and urinary metabolomic profiles of Down syndrome correlate with alteration of mitochondrial metabolism","volume":"8","author":"Caracausi","year":"2018","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-020-00978-4_bib77","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40035-018-0133-9","article-title":"Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome","volume":"7","author":"Tramutola","year":"2018","journal-title":"Transl Neurodegener"},{"key":"10.1007\/s13311-020-00978-4_bib78","doi-asserted-by":"crossref","first-page":"12529","DOI":"10.18632\/oncotarget.3725","article-title":"Elevated O-GlcNAcylation promotes colonic inflammation and tumorigenesis by modulating NF-kappaB signaling","volume":"6","author":"Yang","year":"2015","journal-title":"Oncotarget."},{"key":"10.1007\/s13311-020-00978-4_bib79","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1038\/oncsis.2014.24","article-title":"OGA heterozygosity suppresses intestinal tumorigenesis in Apc(min\/+) mice","volume":"3","author":"Yang","year":"2014","journal-title":"Oncogenesis."},{"key":"10.1007\/s13311-020-00978-4_bib80","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fendo.2014.00206","article-title":"O-GlcNAcase Expression is Sensitive to Changes in O-GlcNAc Homeostasis","volume":"5","author":"Zhang","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1007\/s13311-020-00978-4_bib81","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1128\/MCB.02393-05","article-title":"Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration","volume":"26","author":"Chang","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1007\/s13311-020-00978-4_bib82","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1083\/jcb.200301115","article-title":"APP processing is regulated by cytoplasmic phosphorylation","volume":"163","author":"Lee","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1007\/s13311-020-00978-4_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12031-007-0001-z","article-title":"Tyr687 dependent APP endocytosis and Abeta production","volume":"32","author":"Rebelo","year":"2007","journal-title":"J Mol Neurosci"},{"key":"10.1007\/s13311-020-00978-4_bib84","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.neurobiolaging.2012.03.001","article-title":"O-linked beta-N-acetylglucosaminidase inhibitor attenuates beta-amyloid plaque and rescues memory impairment","volume":"34","author":"Kim","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.1007\/s13311-020-00978-4_bib85","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1750-1326-9-42","article-title":"Pharmacological inhibition of O-GlcNAcase (OGA) prevents cognitive decline and amyloid plaque formation in bigenic tau\/APP mutant mice","volume":"9","author":"Yuzwa","year":"2014","journal-title":"Mol Neurodegener"},{"key":"10.1007\/s13311-020-00978-4_bib86","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/1567205012666150921095505","article-title":"Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome","volume":"13","author":"Hamlett","year":"2016","journal-title":"Curr Alzheimer Res"},{"key":"10.1007\/s13311-020-00978-4_bib87","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.expneurol.2016.06.006","article-title":"Experience-dependent reduction of soluble beta-amyloid oligomers and rescue of cognitive abilities in middle-age Ts65Dn mice, a model of Down syndrome","volume":"283","author":"Sansevero","year":"2016","journal-title":"Exp Neurol"},{"key":"10.1007\/s13311-020-00978-4_bib88","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0166-4328(02)00082-7","article-title":"Frontal cortex BDNF levels correlate with working memory in an animal model of Down syndrome","volume":"139","author":"Bimonte-Nelson","year":"2003","journal-title":"Behav Brain Res"},{"key":"10.1007\/s13311-020-00978-4_bib89","doi-asserted-by":"crossref","first-page":"16825","DOI":"10.1038\/s41598-017-17201-8","article-title":"Aerobic exercise and a BDNF-mimetic therapy rescue learning and memory in a mouse model of Down syndrome","volume":"7","author":"Parrini","year":"2017","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-020-00978-4_bib90","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1021\/acschemneuro.8b00015","article-title":"Pharmacological Inhibition of O-GlcNAcase Enhances Autophagy in Brain through an mTOR-Independent Pathway","volume":"9","author":"Zhu","year":"2018","journal-title":"ACS Chem Neurosci"},{"key":"10.1007\/s13311-020-00978-4_bib91","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","article-title":"Methods in mammalian autophagy research","volume":"140","author":"Mizushima","year":"2010","journal-title":"Cell."},{"key":"10.1007\/s13311-020-00978-4_bib92","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/prca.201300066","article-title":"Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics","volume":"8","author":"Perluigi","year":"2014","journal-title":"Proteomics Clin Appl"},{"key":"10.1007\/s13311-020-00978-4_bib93","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.freeradbiomed.2014.03.027","article-title":"Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease","volume":"71","author":"Di Domenico","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"10.1007\/s13311-020-00978-4_bib94","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3233\/JAD-141254","article-title":"Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1\/BVR-a system: insights for transition to Alzheimer's disease","volume":"44","author":"Di Domenico","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s13311-020-00978-4_bib95","first-page":"1249","article-title":"Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: redox proteomics analysis of human brain","volume":"2013","author":"Di Domenico","year":"1832","journal-title":"Biochim Biophys Acta"},{"key":"10.1007\/s13311-020-00978-4_bib96","doi-asserted-by":"crossref","first-page":"101162","DOI":"10.1016\/j.redox.2019.101162","article-title":"Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome","volume":"23","author":"Di Domenico","year":"2019","journal-title":"Redox Biol"},{"key":"10.1007\/s13311-020-00978-4_bib97","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1016\/j.cub.2019.08.003","article-title":"Neuronal O-GlcNAcylation Improves Cognitive Function in the Aged Mouse Brain","volume":"29","author":"Wheatley","year":"2019","journal-title":"Curr Biol"},{"key":"10.1007\/s13311-020-00978-4_bib98","doi-asserted-by":"crossref","first-page":"34472","DOI":"10.1074\/jbc.R114.601351","article-title":"The emerging link between O-GlcNAc and Alzheimer disease","volume":"289","author":"Zhu","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-020-00978-4_bib99","doi-asserted-by":"crossref","first-page":"21411","DOI":"10.1074\/jbc.M800677200","article-title":"Regulation of the O-linked beta-N-acetylglucosamine transferase by insulin signaling","volume":"283","author":"Whelan","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-020-00978-4_bib100","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1093\/nar\/gkaa263","article-title":"O-GlcNAc regulates gene expression by controlling detained intron splicing","volume":"48","author":"Tan","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1007\/s13311-020-00978-4_bib101","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.celrep.2017.07.017","article-title":"A Conserved Splicing Silencer Dynamically Regulates O-GlcNAc Transferase Intron Retention and O-GlcNAc Homeostasis","volume":"20","author":"Park","year":"2017","journal-title":"Cell Rep"},{"key":"10.1007\/s13311-020-00978-4_bib102","doi-asserted-by":"crossref","unstructured":"Morino K, Maegawa H. Role of O-GlcNAcylation in the Homeostasis of Metabolic Organs and its Potential Links with Diabetes and its Complications. J Diabetes Investig 2020.","DOI":"10.1111\/jdi.13359"},{"key":"10.1007\/s13311-020-00978-4_bib103","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1042\/BCJ20170006","article-title":"The sweet side of AMPK signaling: regulation of GFAT1","volume":"474","author":"Scott","year":"2017","journal-title":"Biochem J"},{"key":"10.1007\/s13311-020-00978-4_bib104","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1042\/BCJ20160980","article-title":"GFAT1 phosphorylation by AMPK promotes VEGF-induced angiogenesis","volume":"474","author":"Zibrova","year":"2017","journal-title":"Biochem J"},{"key":"10.1007\/s13311-020-00978-4_bib105","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00125-012-2644-8","article-title":"Regulation of insulin sensitivity by serine\/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2","volume":"55","author":"Copps","year":"2012","journal-title":"Diabetologia."},{"key":"10.1007\/s13311-020-00978-4_bib106","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nchembio.797","article-title":"Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation","volume":"8","author":"Yuzwa","year":"2012","journal-title":"Nat Chem Biol"},{"key":"10.1007\/s13311-020-00978-4_bib107","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.neuropharm.2013.11.025","article-title":"Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy","volume":"79","author":"Graham","year":"2014","journal-title":"Neuropharmacology."},{"key":"10.1007\/s13311-020-00978-4_bib108","doi-asserted-by":"crossref","first-page":"e35277","DOI":"10.1371\/journal.pone.0035277","article-title":"Differential effects of an O-GlcNAcase inhibitor on tau phosphorylation","volume":"7","author":"Yu","year":"2012","journal-title":"PLoS One"},{"key":"10.1007\/s13311-020-00978-4_bib109","first-page":"1093","article-title":"The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a Down syndrome mouse model","volume":"2016","author":"Valenti","year":"1862","journal-title":"Biochim Biophys Acta"},{"key":"10.1007\/s13311-020-00978-4_bib110","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1039\/b704905f","article-title":"O-GlcNAc modification in diabetes and Alzheimer's disease","volume":"3","author":"Dias","year":"2007","journal-title":"Mol BioSyst"},{"key":"10.1007\/s13311-020-00978-4_bib111","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1039\/c0mb00337a","article-title":"Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation","volume":"7","author":"Smet-Nocca","year":"2011","journal-title":"Mol BioSyst"},{"key":"10.1007\/s13311-020-00978-4_bib112","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.freeradbiomed.2017.09.013","article-title":"Down syndrome, beta-amyloid and neuroimaging","volume":"114","author":"Head","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"10.1007\/s13311-020-00978-4_bib113","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1089\/ars.2016.6686","article-title":"Polyubiquitinylation Profile in Down Syndrome Brain Before and After the Development of Alzheimer Neuropathology","volume":"26","author":"Tramutola","year":"2017","journal-title":"Antioxid Redox Signal"},{"key":"10.1007\/s13311-020-00978-4_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)","volume":"12","author":"Klionsky","year":"2016","journal-title":"Autophagy."},{"key":"10.1007\/s13311-020-00978-4_bib115","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6279313","article-title":"Modulation of O-GlcNAcylation Regulates Autophagy in Cortical Astrocytes","volume":"2019","author":"Rahman","year":"2019","journal-title":"Oxidative Med Cell Longev"},{"key":"10.1007\/s13311-020-00978-4_bib116","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ncb3066","article-title":"O-GlcNAc-modification of SNAP-29 regulates autophagosome maturation","volume":"16","author":"Guo","year":"2014","journal-title":"Nat Cell Biol"},{"key":"10.1007\/s13311-020-00978-4_bib117","doi-asserted-by":"crossref","first-page":"57186","DOI":"10.18632\/oncotarget.11083","article-title":"O-GlcNAcylation of ATG4B positively regulates autophagy by increasing its hydroxylase activity","volume":"7","author":"Jo","year":"2016","journal-title":"Oncotarget."},{"key":"10.1007\/s13311-020-00978-4_bib118","doi-asserted-by":"crossref","first-page":"e62459","DOI":"10.1371\/journal.pone.0062459","article-title":"Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice","volume":"8","author":"Ozcelik","year":"2013","journal-title":"PLoS One"},{"key":"10.1007\/s13311-020-00978-4_bib119","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/brain\/aws143","article-title":"Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy","volume":"135","author":"Schaeffer","year":"2012","journal-title":"Brain."},{"key":"10.1007\/s13311-020-00978-4_bib120","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2174\/1567205011310040008","article-title":"Autophagy enhancer carbamazepine alleviates memory deficits and cerebral amyloid-beta pathology in a mouse model of Alzheimer's disease","volume":"10","author":"Li","year":"2013","journal-title":"Curr Alzheimer Res"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00978-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-020-00978-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923012011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923012011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00978-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:05:15Z","timestamp":1761807915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923012011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":120,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1878747923012011"],"URL":"https:\/\/doi.org\/10.1007\/s13311-020-00978-4","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Dysregulation of OGT\/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-020-00978-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The authors. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}